Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.510
+0.100 (7.09%)
At close: Apr 17, 2026, 4:00 PM EDT
1.491
-0.019 (-1.28%)
After-hours: Apr 17, 2026, 7:43 PM EDT
Cardiol Therapeutics Employees
Cardiol Therapeutics had 18 employees as of December 31, 2024. The number of employees increased by 12 or 200.00% compared to the previous year.
Employees
18
Change
12
Growth
200.00%
Revenue / Employee
n/a
Profits / Employee
-$1,370,286
Market Cap
168.57M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 18 | - | - |
| Dec 31, 2018 | 6 | - | - |
| Sep 30, 2018 | 8 | - | - |
| Jun 30, 2018 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,137 |
| Aurora Cannabis | 1,073 |
| Organogenesis Holdings | 854 |
| Lifecore Biomedical | 382 |
| Evolus | 334 |
| Anika Therapeutics | 235 |
| Alpha Teknova | 158 |
| Journey Medical | 58 |
CRDL News
- 5 days ago - Cardiol Therapeutics to Highlight MAVERIC Phase III Trial and Recently Published ARCHER Results in Live Interview with Barchart - Newsfile Corp
- 13 days ago - Cardiol Therapeutics (CRDL) Receives 'Buy' Rating from Canaccord Genuity | CRDL Stock News - GuruFocus
- 18 days ago - Cardiol Therapeutics Announces Year-End 2025 Update on Operations - Newsfile Corp
- 6 weeks ago - Cardiol Therapeutics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
- 7 weeks ago - Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference - Newsfile Corp
- 2 months ago - Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure - Newsfile Corp
- 3 months ago - Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million - Newsfile Corp
- 3 months ago - Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million - Newsfile Corp